These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 9087985

  • 1. Hydrocephalic parkinsonism due to Paget's disease of bone: dramatic improvement following ventriculoperitoneal shunt and temporary levodopa/carbidopa therapy.
    Ikeda K, Kinoshita M, Aoki K, Tomatsuri A.
    Mov Disord; 1997 Mar; 12(2):241-2. PubMed ID: 9087985
    [No Abstract] [Full Text] [Related]

  • 2. Surgical management of hydrocephalic dementia in Paget's disease of bone: the 6-year outcome of ventriculo-peritoneal shunting.
    Roohi F, Mann D, Kula RW.
    Clin Neurol Neurosurg; 2005 Jun; 107(4):325-8. PubMed ID: 15885393
    [Abstract] [Full Text] [Related]

  • 3. Amantadine-induced "vocal" myoclonus.
    Pfeiffer RF.
    Mov Disord; 1996 Jan; 11(1):104-6. PubMed ID: 8771080
    [No Abstract] [Full Text] [Related]

  • 4. Use of carbidopa-levodopa in a patient with hydrocephalus and frozen movement.
    Aggarwal S, Childers MK, Jimenez D.
    Brain Inj; 1997 Nov; 11(11):831-6. PubMed ID: 9354260
    [Abstract] [Full Text] [Related]

  • 5. Unforeseen beneficial effects of controlled-release levodopa-carbidopa (Sinemet CR).
    Makela EH, Cutlip WD.
    J Neuropsychiatry Clin Neurosci; 1992 Nov; 4(2):234-5. PubMed ID: 1627988
    [No Abstract] [Full Text] [Related]

  • 6. Square-wave action dystonia in Parkinson's disease.
    van den Munckhof P, Lenz FA, Chase TN.
    Mov Disord; 1998 Mar; 13(2):354-6. PubMed ID: 9539355
    [No Abstract] [Full Text] [Related]

  • 7. Enteral levodopa/carbidopa infusion in advanced Parkinson disease: long-term exposure.
    Nyholm D, Lewander T, Johansson A, Lewitt PA, Lundqvist C, Aquilonius SM.
    Clin Neuropharmacol; 2008 Mar; 31(2):63-73. PubMed ID: 18382177
    [Abstract] [Full Text] [Related]

  • 8. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.
    Nyholm D, Nilsson Remahl AI, Dizdar N, Constantinescu R, Holmberg B, Jansson R, Aquilonius SM, Askmark H.
    Neurology; 2005 Jan 25; 64(2):216-23. PubMed ID: 15668416
    [Abstract] [Full Text] [Related]

  • 9. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS, Kirby L, Kumar D, Cullen EI, Pratt RD, Hahne WA.
    Br J Clin Pharmacol; 2004 Nov 25; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [Abstract] [Full Text] [Related]

  • 10. Case report: successful use of rectally administered levodopa-carbidopa.
    Cooper SD, Ismail HA, Frank C.
    Can Fam Physician; 2001 Jan 25; 47():112-3. PubMed ID: 11212422
    [No Abstract] [Full Text] [Related]

  • 11. Reversible parkinsonism following ventriculoperitoneal shunt in a patient with obstructive hydrocephalus secondary to intraventricular neurocysticercosis.
    Prashantha DK, Netravathi M, Ravishankar S, Panda S, Pal PK.
    Clin Neurol Neurosurg; 2008 Jul 25; 110(7):718-21. PubMed ID: 18440127
    [Abstract] [Full Text] [Related]

  • 12. Management of hydrocephalus in Paget's disease. Case report.
    Aguiar PH, Andrioli MS, Cabrera HN, Cabral ND, Scaff M.
    Zentralbl Neurochir; 1994 Jul 25; 55(1):60-2. PubMed ID: 8053279
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Augmentation of artistic productivity in Parkinson's disease.
    Walker RH, Warwick R, Cercy SP.
    Mov Disord; 2006 Feb 25; 21(2):285-6. PubMed ID: 16261619
    [No Abstract] [Full Text] [Related]

  • 15. Carbidopa/levodopa therapy of coexistent drug-induced parkinsonism and tardive dyskinesia.
    Shoulson I.
    Adv Neurol; 1983 Feb 25; 37():259-66. PubMed ID: 6134445
    [No Abstract] [Full Text] [Related]

  • 16. OFF-off rebound dyskinesia in subthalamic nucleus deep brain stimulation of Parkinson's disease.
    Brodsky MA, Hogarth P, Nutt JG.
    Mov Disord; 2006 Sep 25; 21(9):1487-90. PubMed ID: 16721730
    [Abstract] [Full Text] [Related]

  • 17. Reducing dosing frequency of carbidopa/levodopa: double-blind crossover study comparing twice-daily bilayer formulation of carbidopa/levodopa (IPX054) versus 4 daily doses of standard carbidopa/levodopa in stable Parkinson disease patients.
    Hinson VK, Goetz CG, Leurgans S, Fan W, Nguyen T, Hsu A.
    Clin Neuropharmacol; 2009 Sep 25; 32(4):189-92. PubMed ID: 19620848
    [Abstract] [Full Text] [Related]

  • 18. [Treatment of parkinsonism by L-dopa and dopa-decarboxylase inhibitor in a single tablet].
    Sarova-Pinhas I, Braham J.
    Harefuah; 1974 Sep 01; 87(5):208-10. PubMed ID: 4435614
    [No Abstract] [Full Text] [Related]

  • 19. Parkinsonism--dementia complex, hydrocephalus and Paget's disease.
    Botez MI, Bertrand G, Léveillé J, Marchand L.
    Can J Neurol Sci; 1977 May 01; 4(2):139-42. PubMed ID: 851913
    [Abstract] [Full Text] [Related]

  • 20. [Current status of antiparkinson therapy].
    Pendefunda G.
    Rev Med Chir Soc Med Nat Iasi; 1977 May 01; 81(1):151-6. PubMed ID: 866829
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.